IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v20y2023i6p5129-d1097429.html
   My bibliography  Save this article

A Survey of Cannabis Use among Patients with Inflammatory Bowel Disease (IBD)

Author

Listed:
  • Alondra Velez-Santiago

    (Department of Medicine, School of Medicine, University of Puerto Rico Medical Sciences Campus, PR Medical Center, San Juan, PR 00935, USA)

  • Edwin Alvarez-Torres

    (Department of Medicine, School of Medicine, University of Puerto Rico Medical Sciences Campus, PR Medical Center, San Juan, PR 00935, USA)

  • Ricardo Martinez-Rodriguez

    (Department of Medicine, School of Medicine, University of Puerto Rico Medical Sciences Campus, PR Medical Center, San Juan, PR 00935, USA)

  • Emmanuel Candal-Rivera

    (Veterans Affairs Caribbean Health System, 10 Calle Casia, San Juan, PR 00921-3201, USA)

  • Luis Muniz-Camacho

    (Veterans Affairs Caribbean Health System, 10 Calle Casia, San Juan, PR 00921-3201, USA
    These authors contributed equally to this work.)

  • Luis Ramos-Burgos

    (Massachussetts General Hospital, 55 Fruit St., Boston, MA 02114, USA
    These authors contributed equally to this work.)

  • Esther A. Torres

    (Department of Medicine, School of Medicine, University of Puerto Rico Medical Sciences Campus, PR Medical Center, San Juan, PR 00935, USA)

Abstract

Inflammatory bowel diseases (IBDs) are chronic conditions of unknown cause or cure. Treatment seeks to reduce symptoms and induce and maintain remission. Many patients have turned to alternatives, such as cannabis, to alleviate living with IBD. This study reports the demographics, prevalence, and perception on cannabis use of patients attending an IBD clinic. Patients agreed to participate and completed an anonymous survey during their visit or online. Descriptive analysis, Fisher’s exact test, and Wilcoxon-Mann-Whitney rank-sum test were used. One hundred and sixty-two adults (85 males, 77 with CD) completed the survey. Sixty (37%) reported use of cannabis, of which 38 (63%) used it to relieve their IBD. A value of 77% reported low to moderate knowledge about cannabis, and 15% reported little to no knowledge. Among cannabis users, 48% had discussed use with their physician, but 88% said they would feel comfortable discussing medical cannabis for IBD. Most saw improvement of their symptoms (85.7%). A considerable number of patients with IBD use medical cannabis for their disease, unknown to their physician. The study reinforces the importance that physicians understand the role of cannabis in the treatment of IBD in order to appropriately counsel patients.

Suggested Citation

  • Alondra Velez-Santiago & Edwin Alvarez-Torres & Ricardo Martinez-Rodriguez & Emmanuel Candal-Rivera & Luis Muniz-Camacho & Luis Ramos-Burgos & Esther A. Torres, 2023. "A Survey of Cannabis Use among Patients with Inflammatory Bowel Disease (IBD)," IJERPH, MDPI, vol. 20(6), pages 1-11, March.
    • Handle: RePEc:gam:jijerp:v:20:y:2023:i:6:p:5129-:d:1097429
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/20/6/5129/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/20/6/5129/
    Download Restriction: no
    ---><---

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:20:y:2023:i:6:p:5129-:d:1097429. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.